1100682

Acorda Therapeutics, Inc. — FEI 3002457563

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 19, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pearl River, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)